Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions.

Marieke Sternkopf , Magdolna Nagy , Constance C.F.M.J. Baaten , Marijke J.E. Kuijpers
Arteriosclerosis, Thrombosis, and Vascular Biology 40 ( 3)

15
2020
Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia

Elke Marsch , Jasper A.F. Demandt , Thomas L. Theelen , Bibian M.E. Tullemans
European Heart Journal 37 ( 39) 2993 -2997

28
2016
Acquired platelet antagonism: off-target antiplatelet effects of malignancy treatment with tyrosine kinase inhibitors.

B. M. E. Tullemans , J. W. M. Heemskerk , M. J. E. Kuijpers
Journal of Thrombosis and Haemostasis 16 ( 9) 1686 -1699

33
2018
Characterization of cerebral small vessel disease by neutrophil and platelet activation markers using artificial intelligence

MFA Karel , MGCH Roosen , BME Tullemans , C Eleana Zhang
Journal of Neuroimmunology 367 577863 -577863

10
2022
Paradoxical impaired platelet-dependent arterial thrombus and fibrin formation in patients with protein C or protein S deficiency

SLN Brouns , BME Tullemans , C Bulato , G Perrella
New insights in thrombus interactions: unravelling bleeding and thrombotic phenotypes 121 -121

2021
Multiparameter screening for platelet-inhibitory effects of tyrosine kinase inhibitors used for cancer treatment

BME Tullemans , A Veninga , DI Fernandez , MJB Aarts
Tyrosine kinase inhibitors for cancer treatment: Effects on platelets 151 -151

2021
The effect of Bruton's tyrosine kinase inhibitor ibrutinib on atherothrombus formation under stenotic flow conditions

MFA Karel , BME Tullemans , G D'Italia , TP Lemmens
Thrombosis Research 212 72 -80

5
2022
Characterization of atherosclerotic plaque coating for thrombosis microfluidics assays

MFA Karel , TP Lemmens , BME Tullemans , SJH Wielders
Cellular and Molecular Bioengineering 1 -11

4
2021
Heterogeneity in Agonist-induced Activation Responses and Thrombus Formation: Differences between Large and Small Platelets

S Handtke , B Tullemans , S Brouns , R Palankar
Hämostaseologie 39 ( S 01) P05 -8

2019
Design, manufacturing and testing of a green non-isocyanate polyurethane prosthetic heart valve

Sofia F Melo , Alicia Nondonfaz , Abdelhafid Aqil , Anna Pierrard
Biomaterials Science 12 ( 8) 2149 -2164

1
2024
Structure-based cyclic glycoprotein ibα-derived peptides interfering with von Willebrand factor-binding, affecting platelet aggregation under shear

Johana Hrdinova , Delia I Fernández , Bogac Ercig , Bibian ME Tullemans
International journal of molecular sciences 23 ( 4) 2046 -2046

11
2022
Protein C or Protein S deficiency associates with paradoxically impaired platelet‐dependent thrombus and fibrin formation under flow

Sanne LN Brouns , Bibian ME Tullemans , Cristiana Bulato , Gina Perrella
Research and practice in thrombosis and haemostasis 6 ( 2) e12678 -e12678

6
2022
Effects of platelet agonists and priming on the formation of platelet populations

Alicia Veninga , Constance CFMJ Baaten , Ilaria De Simone , Bibian ME Tullemans
Thrombosis and Haemostasis 122 ( 05) 726 -738

20
2022
GPVI expression is linked to platelet size, age, and reactivity

Alicia Veninga , Stefan Handtke , Konstanze Aurich , Bibian ME Tullemans
Blood advances 6 ( 14) 4162 -4173

16
2022
Tyrosine kinase inhibitor Sunitinib delays platelet-induced coagulation: additive effects of aspirin

Bibian ME Tullemans , Delia I Fernández , Alicia Veninga , Constance CFMJ Baaten
Thrombosis and Haemostasis 122 ( 01) 092 -104

11
2022
Multiparameter evaluation of the platelet-inhibitory effects of tyrosine kinase inhibitors used for cancer treatment

Bibian ME Tullemans , Alicia Veninga , Delia I Fernandez , Maureen JB Aarts
International Journal of Molecular Sciences 22 ( 20) 11199 -11199

8
2021
Maintenance of murine platelet homeostasis by the kinase Csk and phosphatase CD148.

Jun Mori , Zoltan Nagy , Giada Di Nunzio , Christopher W Smith
Blood 131 ( 10) 1122 -1144

23
2018